The Influence of Pharmacogenetics on Fatty Liver Disease in the Wistar and Kyoto Rats: A Combined Transcriptomic and Metabonomic Study
- 13 December 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 6 (1), 54-61
- https://doi.org/10.1021/pr0601640
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liverPhysiological Genomics, 2004
- Nonalcoholic fatty liver disease: An agenda for clinical researchHepatology, 2002
- Etiopathogenesis of Nonalcoholic SteatohepatitisSeminars in Liver Disease, 2001
- Nonalcoholic Fatty Liver DiseaseDiabetes, 2001
- Metabolic Profiling of Genetic Disorders: A Multitissue 1H Nuclear Magnetic Resonance Spectroscopic and Pattern Recognition Study into Dystrophic TissueAnalytical Biochemistry, 2001
- High-resolution1H and1H-13C magic angle spinning NMR spectroscopy of rat liverMagnetic Resonance in Medicine, 2000
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999
- TIP49, Homologous to the Bacterial DNA Helicase RuvB, Acts as an Autoantigen in HumanBiochemical and Biophysical Research Communications, 1998
- The mechanism of inhibition of lipoprotein synthesis by orotic acidBiochemical and Biophysical Research Communications, 1965
- Metabolic aspects of ‘orotic acid fatty liver’. Nucleotide control mechanisms of lipid metabolismBiochemical Journal, 1964